Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Rizzi

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Current Neuropharmacology|September 16, 2022
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral SclerosisRamona Meanti, Elena Bresciani, Laura Rizzi, et al.
European Journal of Clinical Pharmacology|June 19, 2012
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary careGianluca Trifirò, Silvia Tillati, Edoardo Spina, et al.
Endocrinology|July 10, 2013
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structureAntonella Liantonio, Gianluca Gramegna, Giuseppe Carbonara, et al.
Frontiers in Pharmacology|December 14, 2018
STIM Proteins and Orai Ca<sup>2+</sup> Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 MacrophagesLaura Molteni, Laura Rizzi, Elena Bresciani, et al.
Parkinsonism & Related Disorders|May 25, 2016
Advanced therapies in Parkinson's disease: Long-term retrospective studyAristide Merola, Alberto J Espay, Alberto Romagnolo, et al.
Frontiers in Pharmacology|May 29, 2019
miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/RitonavirElena Bresciani, Cecilia Saletti, Nicola Squillace, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2011
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?Aristide Merola, Maurizio Zibetti, Carlo Alberto Artusi, et al.
Journal of the International AIDS Society|August 24, 2014
Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapyAnna M Grandi, Eleonora Nicolini, Laura Rizzi, et al.
Journal of Neurology|October 21, 2016
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson diseaseAristide Merola, Alberto Romagnolo, Laura Rizzi, et al.
International Journal of Molecular Sciences|April 3, 2021
Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective EffectsAlessia D'Aloia, Laura Molteni, Francesca Gullo, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Current Neuropharmacology|September 16, 2022
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral SclerosisRamona Meanti, Elena Bresciani, Laura Rizzi, et al.
European Journal of Clinical Pharmacology|June 19, 2012
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary careGianluca Trifirò, Silvia Tillati, Edoardo Spina, et al.
Endocrinology|July 10, 2013
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structureAntonella Liantonio, Gianluca Gramegna, Giuseppe Carbonara, et al.
Frontiers in Pharmacology|December 14, 2018
STIM Proteins and Orai Ca<sup>2+</sup> Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 MacrophagesLaura Molteni, Laura Rizzi, Elena Bresciani, et al.
Parkinsonism & Related Disorders|May 25, 2016
Advanced therapies in Parkinson's disease: Long-term retrospective studyAristide Merola, Alberto J Espay, Alberto Romagnolo, et al.
Frontiers in Pharmacology|May 29, 2019
miRNA-218 Targets Lipin-1 and Glucose Transporter Type 4 Genes in 3T3-L1 Cells Treated With Lopinavir/RitonavirElena Bresciani, Cecilia Saletti, Nicola Squillace, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2011
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?Aristide Merola, Maurizio Zibetti, Carlo Alberto Artusi, et al.
Journal of the International AIDS Society|August 24, 2014
Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapyAnna M Grandi, Eleonora Nicolini, Laura Rizzi, et al.
Journal of Neurology|October 21, 2016
Impulse control behaviors and subthalamic deep brain stimulation in Parkinson diseaseAristide Merola, Alberto Romagnolo, Laura Rizzi, et al.
International Journal of Molecular Sciences|April 3, 2021
Palmitoylethanolamide Modulation of Microglia Activation: Characterization of Mechanisms of Action and Implication for Its Neuroprotective EffectsAlessia D'Aloia, Laura Molteni, Francesca Gullo, et al.
Pageof 8